Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

MLA

de Haas, Ria, et al. “Therapeutic Effects of the Mitochondrial ROS-Redox Modulator KH176 in a Mammalian Model of Leigh Disease.” Scientific Reports, vol. 7, no. 1, Sept. 2017, p. 11733. EBSCOhost, https://doi.org/10.1038/s41598-017-09417-5.

APA

de Haas, R., Das, D., Garanto, A., Renkema, H. G., Greupink, R., van den Broek, P., Pertijs, J., Collin, R. W. J., Willems, P., Beyrath, J., Heerschap, A., Russel, F. G., & Smeitink, J. A. (2017). Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease. Scientific Reports, 7(1), 11733. https://doi.org/10.1038/s41598-017-09417-5

Chicago

de Haas, Ria, Devashish Das, Alejandro Garanto, Herma G Renkema, Rick Greupink, Petra van den Broek, Jeanne Pertijs, et al. 2017. “Therapeutic Effects of the Mitochondrial ROS-Redox Modulator KH176 in a Mammalian Model of Leigh Disease.” Scientific Reports 7 (1): 11733. doi:10.1038/s41598-017-09417-5.